Zimmer Biomet (ZBH) Outlines Strategy to Deliver Above Market Growth
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
RBC Capital Reiterates Outperform Rating on Zimmer Biomet (ZBH)
May 30, 2024 6:24 AM EDTRBC Capital analyst Shagun Singh reiterated an Outperform rating and $140.00 price target on Zimmer Biomet (NYSE: ZBH)
The analyst comments "ZBH hosted its first investor day today (5/29) at the NYSE, laying out its long-term financial and strategic roadmap. Notably, ZBH expects to deliver... More
Citi Reiterates Neutral Rating on Zimmer Biomet (ZBH)
May 30, 2024 5:38 AM EDTCiti analyst Joanna Wuensch reiterated a Neutral rating and $134.00 price target on Zimmer Biomet (NYSE: ZBH).
The analyst comments "ZBH held its first analyst meeting (ever) today, and while some may question if it can deliver 5-6% organic revenue growth in 2024,... More
